HK's Haitong leads Series B funding for US biotech firm Orig3n

HK's Haitong leads Series B funding for US biotech firm Orig3n

Orig3n CEO Robin Smith and COO Kate Blanchard. Photo from Facebook page of Orig3n.

Haitong InternationalORIG3N

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.